X4 Pharmaceuticals
NASDAQ: XFOR
Healthcare
Biotechnology
Rank
#34393
Market Cap
22.29 M
Volume
20,651
Price
3.85
Change (%)
2.67%
Country or region
United States
United States
X4 Pharmaceuticals's latest marketcap:
22.29 M
As of May 2, 2025, X4 Pharmaceuticals's market capitalization has reached $22.29 M. According to our data, X4 Pharmaceuticals is the 34393th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 22.29 M |
| Revenue (ttm) | 31.36 M |
| Net Income (ttm) | 14.60 M |
| Shares Out | 5.79 M |
| EPS (ttm) | 2.16 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | May 1, 2025 |
Market Cap Chart
Data Updated: May 2, 2025
X4 Pharmaceuticals's yearly market capitalization.
X4 Pharmaceuticals has seen its market value drop from $104.72 M to $33.13 M since 2020, representing a total decrease of 68.36% and an annual compound decline rate (CAGR) of 23.51%.
| Date | Market Cap | Change (%) |
|---|---|---|
| April 17, 2025 | $33.13 M | -73.52% |
| December 31, 2024 | $125.11 M | -10.81% |
| December 29, 2023 | $140.27 M | 16.23% |
| December 30, 2022 | $120.68 M | 87.36% |
| December 31, 2021 | $64.41 M | -38.49% |
| December 31, 2020 | $104.72 M |
Company Profile
Frequently Asked Questions
As of May 2, 2025, X4 Pharmaceuticals (including the parent company, if applicable) has an estimated market capitalization of $22.29 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
X4 Pharmaceuticals global market capitalization ranking is approximately 34393 as of May 2, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 2014 |
| IPO Date | n/a |
| Employees | 143 |
| CEO | |
| Sector | Healthcare |
| Industry | Biotechnology |
| Address |
